Well the saga rolls on and as an industry we remain divided about just how serious this is.
Here is a letter from Alan Rosenbloom the president of ARF The Alpaca Research Foundation.

Folks,

At this point in time the two insurance companies that insure alpacas have received 20 claims for deaths related to "Snots." The majority of information available about this disease is of non-veterinarian origin and may be misleading. All of the cases which have been reported may or may not be the same disorder. All that being said, whatever it is is very contagious and is certainly transmitted from alpaca to alpaca, but very likely also from human to alpaca. There is intensive work ongoing at UC Davis and Washington State to define the cause, but it appears that the majority of deaths may be due to secondary bacterial infection ( if this is, in fact, a viral disease) and/or hepatic lipidosis due to rapid severe weight loss. There is anecdotal evidence to indicate that this disorder has been spread at three shows and at least two veterinary hospitals. There has been a suggestion that this may be an adenovirus, but no hard evidence that I know of. However, adenoviruses have been blamed for just about everything at one time or another. Given the fact that this is still a mystery disease, that it may be very widespread, but that all the cases may, in fact, not be the same disorder, it is difficult to imagine a study done in one area which would guarantee the answer to questions being asked in another area (eg.- what does the outbreak in Washington have to do with the oubreak in California, and what do either of those have to do with the isolated case in Florida?). Therefore, at this time all ARF can do is take the approach of watchful waiting. When WNV and BVDV were apparently becoming a problem, ARF immediately sent out Requests For Proposals (RFP) and research got under way almost immediately. This circumstance is very different and much more difficult to assess. If we get enough valid information to ask the right questions, we will be scouting around for studies to fund. Until then, the answer is the same as it has always been. Biosecurity prevents diseases we know about and ones we have yet to define.
I think it is reasonable to expect AOBA to be silent on this issue for as long as silence can be maintained. This scare could certainly keep people away from shows, and AOBA considers that specter absolutely frightening. It took an incredible amount of arm-twisting to get the AOBA BOD to go along with BVDV testing and this scenario is not much different ARF has contacted Gordon Anderson and informed him of our position on this. I got a simple non-committal reply from him, but he is in no position to do anything else.
Just be careful.

Alan